These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35143561)

  • 1. ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it.
    Kanamarlapudi V; Tamaddon-Jahromi S; Murphy K
    PLoS One; 2022; 17(2):e0263845. PubMed ID: 35143561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis.
    Zhong X; Wen X; Chen L; Gu N; Yu X; Sui K
    J Gene Med; 2021 May; 23(5):e3330. PubMed ID: 33682985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
    Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
    Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APE1 Upregulates MMP-14 via Redox-Sensitive ARF6-Mediated Recycling to Promote Cell Invasion of Esophageal Adenocarcinoma.
    Lu H; Bhat AA; Peng D; Chen Z; Zhu S; Hong J; Maacha S; Yan J; Robbins DJ; Washington MK; Belkhiri A; El-Rifai W
    Cancer Res; 2019 Sep; 79(17):4426-4438. PubMed ID: 31308045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional Regulation.
    O'Neill JR; Yébenes Mayordomo M; Mitulović G; Al Shboul S; Bedran G; Faktor J; Hernychova L; Uhrik L; Gómez-Herranz M; Kocikowski M; Save V; Vojtěšek B; Arends MJ; ; Hupp T; Alfaro JA
    Mol Cell Proteomics; 2024 Jun; 23(6):100764. PubMed ID: 38604503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
    Plum PS; Ulase D; Bollschweiler E; Chon SH; Berlth F; Zander T; Alakus H; Hölscher AH; Bruns CJ; Schallenberg S; Quaas A; Loeser H
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1731-1739. PubMed ID: 29974234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145 suppresses cell migration and invasion in upper tract urothelial carcinoma by targeting ARF6.
    Hsu WC; Li WM; Lee YC; Huang AM; Chang LL; Lin HH; Wu WJ; Li CC; Liang PI; Ke HL
    FASEB J; 2020 Apr; 34(4):5975-5992. PubMed ID: 32077148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.
    Fisher OM; Levert-Mignon AJ; Lord SJ; Botelho NK; Freeman AK; Thomas ML; Falkenback D; Wettstein A; Whiteman DC; Bobryshev YV; Lord RV
    Ann Surg Oncol; 2015 Jul; 22(7):2431-8. PubMed ID: 25348778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk.
    Di Martino E; Wild CP; Rotimi O; Darnton JS; Olliver RJ; Hardie LJ
    Biomarkers; 2006; 11(6):547-61. PubMed ID: 17056474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
    Plum PS; Gebauer F; Krämer M; Alakus H; Berlth F; Chon SH; Schiffmann L; Zander T; Büttner R; Hölscher AH; Bruns CJ; Quaas A; Loeser H
    BMC Cancer; 2019 Jan; 19(1):38. PubMed ID: 30621632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the unique microRNA signature in human esophageal adenocarcinoma.
    Saad R; Chen Z; Zhu S; Jia P; Zhao Z; Washington MK; Belkhiri A; El-Rifai W
    PLoS One; 2013; 8(5):e64463. PubMed ID: 23724052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma.
    Weh KM; Howell AB; Kresty LA
    Mol Carcinog; 2016 Nov; 55(11):1876-1885. PubMed ID: 27696537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in Esophageal Adenocarcinoma: Functional Significance and Potential for the Development of New Molecular Disease Markers.
    Bobryshev YV; Orekhov AN; Chistiakov DA
    Curr Pharm Des; 2015; 21(23):3402-16. PubMed ID: 25758856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin promoter hypermethylation identifies a field defect in human primary esophageal cancer.
    Jin Z; Zhao Z; Cheng Y; Dong M; Zhang X; Wang L; Fan X; Feng X; Mori Y; Meltzer SJ
    Cancer; 2013 Oct; 119(20):3604-9. PubMed ID: 23893879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.
    Watts GS; Tran NL; Berens ME; Bhattacharyya AK; Nelson MA; Montgomery EA; Sampliner RE
    Int J Cancer; 2007 Nov; 121(10):2132-9. PubMed ID: 17594693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma.
    Underwood TJ; Hayden AL; Derouet M; Garcia E; Noble F; White MJ; Thirdborough S; Mead A; Clemons N; Mellone M; Uzoho C; Primrose JN; Blaydes JP; Thomas GJ
    J Pathol; 2015 Feb; 235(3):466-77. PubMed ID: 25345775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.